IDEXX Laboratories stock holds firm on recurring diagnostics demand
IDEXX Laboratories reported strong fiscal 2025 results, with revenue reaching $3.9 billion and an operating margin of 31.0%. The company's profitability and growth are driven by recurring veterinary diagnostics demand, especially a 14% increase in companion animal diagnostic recurring revenue. This consistency in expanding …